Psychopharmacology and Psychiatry Updates

Psychopharmacology and Psychiatry Updates

Por: Psychopharmacology Institute
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
100 episodios disponibles

Latest episodes of the podcast Psychopharmacology and Psychiatry Updates

Mostrando página 4 de 5

After the Last Dose: Understanding Antipsychotic Discontinuation 02/03/2025
Understanding Lamotrigine's Cardiac Effects 25/02/2025
Rethinking Falls: Are Sleep Medications Really to Blame? 20/02/2025
Navigating Lamotrigine's Side Effects 15/02/2025
Iloperidone in Bipolar Disorder: A New Treatment Option? 10/02/2025
Lamotrigine: Pearls for Prescribing 05/02/2025
Beyond Benzos: New Frontiers in Agitation Management 31/01/2025
KarXT: A New Dawn in Antipsychotic Treatment 26/01/2025
Rethinking Agitation Management: From Force to Partnership 21/01/2025
COVID Brain Fog: Repurposing Famotidine 16/01/2025
Beyond Restraints: De-Escalation in Behavioral Emergencies 11/01/2025
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial 06/01/2025
Unraveling Agitation: Mania vs. Substance Use 01/01/2025
Pushing the Boundaries: Exploring High-Dose Antipsychotics 27/12/2024
The Psychodynamic Prescriber 22/12/2024
From Inpatient to Outpatient: Initiating Benzodiazepine Tapering 17/12/2024
The Power of Alliance in Psychopharmacology 12/12/2024
Antipsychotics in Youth: Balancing Metabolic Risk 07/12/2024
The Double-Edged Sword of Biological Explanations in Mental Health 02/12/2024
New Insights into Psychiatric and Cardiovascular Comorbidity 27/11/2024
« Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA